Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
Strongyloides Antibody, IgG
Methamphetamine, Urine
Activated Protein C Resistance V (APCRV)
Hypochondroplasia (FGFR3) Gene Mutation Analysis
Lysosomal Acid Lipase, Gene Variation
Carcinoembryonic Antigen (CEA), Pleural Fluid
Potassium, 24 Hour, Urine
PPOX Gene Mutation Analysis, Tissue
ATM/C11orf65 Gene Variation
LDS
Sign up
Log in
LDS
/
Medical Tests
/
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test
Specimen Collection
Access to
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
is restricted.
Sign up now
Loading...